Intended for healthcare professionals

This Week In The Bmj

Misoprostol helps anaemic women in childbirth

BMJ 2005; 331 doi: (Published 29 September 2005) Cite this as: BMJ 2005;331:0

Routine use of misoprostol as a sublingual tablet may reduce postpartum morbidity and mortality in developing countries, where many pregnant women are anaemic. In a randomised double blind placebo controlled trial of 661 women in Guinea-Bissau, H⊘j and colleagues (p 723) found that 600 μg misoprostol significantly reduced the incidence of severe postpartum haemorrhage. Compared with women randomised to placebo, women who received the drug lost less blood and had a smaller decrease in haemoglobin concentration.

Embedded Image